Altogether, our present study demonstrates that the malfunction of Nrf2 is defined as a tumor promoter, but it is predominantly suppressed by Nrf1α, that acts as a dominant tumor repressor, specifically through transcriptional regulation of the 26S proteasome-mediated Nrf2 degradation pathways. Here, NFE2L2 is linked to neoplasm.